US Stock MarketDetailed Quotes

SHTDY SINOPHARM GROUP CO

Watchlist
  • 11.610
  • -0.208-1.76%
15min DelayClose Mar 26 16:00 ET
7.25BMarket Cap7.47P/E (TTM)

About SINOPHARM GROUP CO Company

Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. It operates through the following business segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers and other suppliers. The Medical Devices segment consists of the distribution of medical devices in China. The Retail Pharmacy segment refers to the network of retail drug stores in major cities of China via direct operations and franchises. The Other Business segment comprises of the production and sale of pharmaceutical products, chemical reagents and laboratory supplies. The company was founded on January 8, 2003 and is headquartered in Shanghai, China.

Company Profile

SymbolSHTDY
Company NameSINOPHARM GROUP CO
Listing DateSep 23, 2009
Founded2003
MarketPink Market
Employees115959
Securities TypeDR
ADS Ratio1.0 : 5.0
Fiscal Year Ends12-31
AddressSinopharm Group Building,No. 385, East Longhua Road,Huangpu District
CityShanghai
ProvinceShanghai
CountryChina
Zip Code200023
Phone86-21-6321-1750

Company Executives

  • Name
  • Position
  • Salary
  • Yong Liu
  • Director and President
  • --
  • Qingming Yu
  • Executive Chairman of the Board
  • --
  • Qiyu Chen
  • Vice Chairman of the Board
  • --
  • Peng Wang
  • Director
  • --
  • Jianwei Hu
  • Director
  • --
  • Rongli Feng
  • Director
  • --
  • Deyong Wen
  • Director
  • --
  • Jindong Deng
  • Director
  • --
  • Wang Kan
  • Director
  • --
  • Dongjiu Li
  • Director
  • --
  • Peiyu Li
  • Independent Director
  • --
  • Weifeng Yu
  • Independent Director
  • --
  • Tak Lung Wu
  • Independent Director
  • --
  • Shenghao Shi
  • Independent Director
  • --
  • Fangruo Chen
  • Independent Director
  • --

Market Insights

Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More